Eric Stecker is a Cardiology physician affiliated with Oregon Health & Science University. OpenAlex indexes 170 publications with 5,227 citations (h-index 30).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3181 SW Sam Jackson Park Rd
Uhn-62
Portland, OR 97239
Telephone
503-494-8750Registry record last updated 12 Aug 2008.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
58.2%Antiarrhythmic29.8%Amiodarone Hcl47%Flecainide Acetate29%Dofetilide24%Part D<11 patientsBeta blocker28.4%Metoprolol Succinate69%Sotalol31%Part D≥19 patientsBlood & clotting
37.9%Factor Xa inhibitor37.9%Eliquis79%Xarelto21%Part D<11 patientsMetabolism & gastrointestinal
3.9%Proton pump inhibitor3.9%Omeprazole100%Part D≥11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Cardiovascular disease risk: it is complicated, but race and ethnicity are key, a Bayesian network analysis
Frontiers in Public Health
2024 - Efficacy and safety of dofetilide and sotalol in patients with hypertrophic cardiomyopathy
Communications Medicine
2023 - Ablation Versus Antiarrhythmic Drugs as First-Line Treatment of Paroxysmal Atrial Fibrillation: A Meta-Analysis of Randomized Trials
Circulation Arrhythmia and Electrophysiology
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Eric Orwoll, MD
Oregon Health & Science University
Aaron Caughey, MD
Oregon Health & Science University
Tomasz Beer, MD
Oregon Health & Science University
John Nutt, MD
Oregon Health & Science University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”